eGFR did not significantly change with supplementation vs placebo in patients with type 2 diabetes.
Odds of diabetic kidney disease higher in obese teens receiving medical therapy vs bariatric surgery for T2DM.
Weight management/group medical visit arm had lower diabetes medication use, greater weight loss.
For patients with type 2 diabetes, apparent treatment-resistant hypertension increases risk for cardiovascular events and mortality.
Patients with both T2DM, previous vertebral fracture have twofold risk for incident nonvertebral fracture.
In patients with type 2 diabetes mellitus, anemia is associated with the development of diabetic retinopathy.
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
Mortality risk for flu-related hospitalizations lower for those with vs without type 2 diabetes.
Reduction seen for risk of dialysis, transplantation, or death due to kidney disease.
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.
Rates of both acute and chronic complications significantly increase with increasing HbA1c.
Among older individuals with type 2 diabetes, insulin use is least prevalent in those in good health, and discontinuation of insulin treatment is most likely in healthier patients.
More primary care for patients with mental health, substance use disorders may affect diabetes severity.
Adjusted uninsured rates down 17% for people with undiagnosed diabetes after ACA.
Cardiorenal disease is commonly the first cardiovascular disease manifestation in patients with type 2 diabetes.
Researchers conducted a systematic review to summarize research that has investigated the effect of healthy lifestyle habits on incident diabetes and prognosis for patients with T2D.
Primary care doctors have limited knowledge about screening, management for prediabetes.
Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
Primary care diabetes prevention programs that promote physical activity become less effective when patients experience depressive symptoms.
Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA treatment.